Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy ...( or otherwise....)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
Date:10/16/2007
, or otherwise.
'/>"/>
| SOURCE Varian Medical Systems Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Using XL1-Red Mutator Strain to Generate Esterase Variants
2. Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing
3. Detection of Apolipoprotein Gene Variants by DGGE Using the DCode System
4. Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae: Detection in vivo using the Varian Cary Eclipse
5. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
6. Minimizing Photobleaching of Blue Fluorescent Protein (BFP) using the Varian Cary Eclipse Fluorescence Spectrophotometer
7. Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS
8. Detection of Alprazolam and Temazepam in a Bovine Plasma Matrix Using the Varian 500-MS Ion Trap Mass Spectrometer
9. Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System
10. Femtogram Sensitivity of the Antipsychotic Drugs Raclopride and Ritanserin Using a Varian 1200L LC/MS/MS
11. Quantitation of a Dinitro Flavonoid (DNF) in Rat Plasma Using the Varian 1200L LC/MS/MS System
Post Your Comments:
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3
[0] Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference[0] YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT[0] China Biologic Products to Ring NASDAQ Opening Bell[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Other Biology Technology:Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 2Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 3Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 4Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 5Hoya Vision Care Expands in Czech Republic 2Creating unconventional metals 2
Breaking Biology News(10 mins):Study reveals H1N1 unexpected weakness 2Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3From fruit fly wings to heart failure -- why Not(ch)? 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 1Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 3CA Representative Elected to Continua Health Alliance Board of Directors 52923 1CA Representative Elected to Continua Health Alliance Board of Directors 52923 2CA Representative Elected to Continua Health Alliance Board of Directors 52923 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 1Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 2Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 4Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 5
Other Biology News:New insights into a leading poultry disease and its risks to human health 2New insights into a leading poultry disease and its risks to human health 3New insights into a leading poultry disease and its risks to human health 4Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3Biggest ever public investment in bioenergy to help provide clean, green and sustainable fuels 2
Biology Products:
Mouse Anti-MDMA Monoclonal Antibody, Unconjugated, Clone 3G8 from AbcamRabbit Anti-Shh Polyclonal Antibody, Unconjugated from Cell Signaling TechnologyMouse Anti-Cohesin (Scc1 / Rad21) Monoclonal Antibody, Unconjugated, Clone CM110-2C10 from MBL InternationalRabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |